Jennifer Gonzalez, PhD
Pharma Panel, Industry Administration & Project Management Panel
Job Title: Senior Scientist/Project Manager/Business Lead
Current Employer: Janssen, Pharmaceutical Companies of Johnson and Johnson
Postdoctoral fellowship at Baylor College of Medicine, Houston, TX (2013)
Ph.D. in Biochemistry and Biophysics, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX (2010)
B.S. in Chemistry, St. Mary’s University, San Antonio, TX (2005)
Following my academic training in the area of ion channel structure/function, I joined Janssen in 2014 as a scientist in Biologics Discovery. I developed proof-of-concept methods and mechanism of action data for candidate lead molecules throughout phases of early discovery and development. I also served as the in-house gene editing (CRISPR/Cas9) subject matter expert and contributed to discovery platforms to develop research tools and for the genetic engineering of cells to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs). As a team lead, I managed immuno-oncology target pre-portfolio projects for efficient and timely entry into the portfolio by defining, optimizing, and tracking implementation of cross- functional team activities for the development and execution of target strategy. I transitioned to a business lead/CAR-T project manager role in BioTherapeutics Analytical Development in 2018. As a project manager for the analytical development of CAR-T projects, I develop and communicate timelines, maintain budgets, efficiently coordinate project activities, and serve as a liaison to our supply chain partners. As a business lead, I develop and analyze resource algorithms for project budget forecasting and provide scientific support for the management of project plans for each large molecule in development and commercial product activities.
Most useful skill sets acquired from/for your field:
What I love most about my job:
There are so many things I love about my job! Having worked in both drug discovery and development, I have contributed to turning molecules into medicine. After working in cell and gene therapy for the last few years, seeing the major impact of CAR-T therapy on patients’ lives is truly rewarding.